Treatment of lung adenocarcinoma with chemotherapy helps mitigate chronic myeloid leukaemia progression: A case report

Treatment outcomes for inoperable advanced non-small cell lung cancer have improved in recent years. However, information on coexisting haematological tumours is lacking. The present patient was a 65-year-old woman with stage IVA lung adenocarcinoma. The patient was administered a combination of pla...

Full description

Saved in:
Bibliographic Details
Published in:Oncology letters 2025-01, Vol.29 (1), Article 31
Main Authors: Nagasue, Kazunori, Kida, Ryotaro, Shigaki, Ryota, Nitanai, Kiichi, Yagita, Akari, Yanada, Hiraku, Umekage, Yasuhiro, Mori, Chie, Minami, Yoshinori, Funayama, Takuya, Yamamoto, Masayo, Tanino, Mishie, Yoshida, Ryohei, Sasaki, Takaaki
Format: Article
Language:English
Subjects:
Biopsy
Blood
Bone marrow
Cancer therapies
Case Report
Case reports
Chemotherapy
Chronic illnesses
Cytotoxicity
Kinases
Leukemia
Lung cancer
Lymphatic system
Metastasis
Mutation
Myelodysplastic syndromes
Radiation
Steroids
Tomography
Tumors
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c302t-2cb7d93e997dd43cef4a4a4ca525d2b3e801116a2b503f69baf174b5a35598323
container_end_page
container_issue 1
container_start_page
container_title Oncology letters
container_volume 29
creator Nagasue, Kazunori
Kida, Ryotaro
Shigaki, Ryota
Nitanai, Kiichi
Yagita, Akari
Yanada, Hiraku
Umekage, Yasuhiro
Mori, Chie
Minami, Yoshinori
Funayama, Takuya
Yamamoto, Masayo
Tanino, Mishie
Yoshida, Ryohei
Sasaki, Takaaki
description Treatment outcomes for inoperable advanced non-small cell lung cancer have improved in recent years. However, information on coexisting haematological tumours is lacking. The present patient was a 65-year-old woman with stage IVA lung adenocarcinoma. The patient was administered a combination of platinum therapy and immune checkpoint inhibitors. The patient was subsequently diagnosed with chronic myeloid leukaemia (CML) following leukocytosis. Carboplatin and pemetrexed combination therapy resulted in shrinkage of lung cancer. Improvements in peripheral blood leukocyte counts and bone marrow findings were observed. These results suggested that the treatment of lung cancer may control the course of CML.
doi_str_mv 10.3892/ol.2024.14777
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11542147</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3134600932</sourcerecordid><originalsourceid>FETCH-LOGICAL-c302t-2cb7d93e997dd43cef4a4a4ca525d2b3e801116a2b503f69baf174b5a35598323</originalsourceid><addsrcrecordid>eNpVUclqw0AMNaWFhjTH3gd6djqL115KCN0g0Et6HuSxHE9qe9yZcUr-vs5CoNJBgifek_SC4J7Ruchy_miaOac8mrMoTdOrYMLSnIeMZvz60qfRbTBzbkvHiBOWZckk2K0tgm-x88RUpBm6DYESO6PAKt2ZFsiv9jVRNbbG12ih35Mam96RVnu9AY8jZk2nFWn32BhdkgaHb8BWA-mt2Vh0TpvuiSyIAofEYm-svwtuKmgczs51Gny9vqyX7-Hq8-1juViFSlDuQ66KtMwF5nlalpFQWEUwpoKYxyUvBGaUMZYAL2IqqiQvoGJpVMQg4jjPBBfT4PnE2w9Fi6Ua77TQyN7qFuxeGtDyP9LpWm7MTjIWR3z85cjwcGaw5mdA5-XWDLYbl5aCiSihND_qhKcpZY1zFquLBKPy4I80jTz4I4_-iD9qQYZv</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3134600932</pqid></control><display><type>article</type><title>Treatment of lung adenocarcinoma with chemotherapy helps mitigate chronic myeloid leukaemia progression: A case report</title><source>PubMed</source><creator>Nagasue, Kazunori ; Kida, Ryotaro ; Shigaki, Ryota ; Nitanai, Kiichi ; Yagita, Akari ; Yanada, Hiraku ; Umekage, Yasuhiro ; Mori, Chie ; Minami, Yoshinori ; Funayama, Takuya ; Yamamoto, Masayo ; Tanino, Mishie ; Yoshida, Ryohei ; Sasaki, Takaaki</creator><creatorcontrib>Nagasue, Kazunori ; Kida, Ryotaro ; Shigaki, Ryota ; Nitanai, Kiichi ; Yagita, Akari ; Yanada, Hiraku ; Umekage, Yasuhiro ; Mori, Chie ; Minami, Yoshinori ; Funayama, Takuya ; Yamamoto, Masayo ; Tanino, Mishie ; Yoshida, Ryohei ; Sasaki, Takaaki</creatorcontrib><description>Treatment outcomes for inoperable advanced non-small cell lung cancer have improved in recent years. However, information on coexisting haematological tumours is lacking. The present patient was a 65-year-old woman with stage IVA lung adenocarcinoma. The patient was administered a combination of platinum therapy and immune checkpoint inhibitors. The patient was subsequently diagnosed with chronic myeloid leukaemia (CML) following leukocytosis. Carboplatin and pemetrexed combination therapy resulted in shrinkage of lung cancer. Improvements in peripheral blood leukocyte counts and bone marrow findings were observed. These results suggested that the treatment of lung cancer may control the course of CML.</description><identifier>ISSN: 1792-1074</identifier><identifier>EISSN: 1792-1082</identifier><identifier>DOI: 10.3892/ol.2024.14777</identifier><language>eng</language><publisher>Athens: Spandidos Publications UK Ltd</publisher><subject>Biopsy ; Blood ; Bone marrow ; Cancer therapies ; Case Report ; Case reports ; Chemotherapy ; Chronic illnesses ; Cytotoxicity ; Kinases ; Leukemia ; Lung cancer ; Lymphatic system ; Metastasis ; Mutation ; Myelodysplastic syndromes ; Radiation ; Steroids ; Tomography ; Tumors</subject><ispartof>Oncology letters, 2025-01, Vol.29 (1), Article 31</ispartof><rights>Copyright Spandidos Publications UK Ltd. 2025</rights><rights>Copyright: © 2024 Nagasue et al. 2024</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c302t-2cb7d93e997dd43cef4a4a4ca525d2b3e801116a2b503f69baf174b5a35598323</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11542147/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11542147/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids></links><search><creatorcontrib>Nagasue, Kazunori</creatorcontrib><creatorcontrib>Kida, Ryotaro</creatorcontrib><creatorcontrib>Shigaki, Ryota</creatorcontrib><creatorcontrib>Nitanai, Kiichi</creatorcontrib><creatorcontrib>Yagita, Akari</creatorcontrib><creatorcontrib>Yanada, Hiraku</creatorcontrib><creatorcontrib>Umekage, Yasuhiro</creatorcontrib><creatorcontrib>Mori, Chie</creatorcontrib><creatorcontrib>Minami, Yoshinori</creatorcontrib><creatorcontrib>Funayama, Takuya</creatorcontrib><creatorcontrib>Yamamoto, Masayo</creatorcontrib><creatorcontrib>Tanino, Mishie</creatorcontrib><creatorcontrib>Yoshida, Ryohei</creatorcontrib><creatorcontrib>Sasaki, Takaaki</creatorcontrib><title>Treatment of lung adenocarcinoma with chemotherapy helps mitigate chronic myeloid leukaemia progression: A case report</title><title>Oncology letters</title><description>Treatment outcomes for inoperable advanced non-small cell lung cancer have improved in recent years. However, information on coexisting haematological tumours is lacking. The present patient was a 65-year-old woman with stage IVA lung adenocarcinoma. The patient was administered a combination of platinum therapy and immune checkpoint inhibitors. The patient was subsequently diagnosed with chronic myeloid leukaemia (CML) following leukocytosis. Carboplatin and pemetrexed combination therapy resulted in shrinkage of lung cancer. Improvements in peripheral blood leukocyte counts and bone marrow findings were observed. These results suggested that the treatment of lung cancer may control the course of CML.</description><subject>Biopsy</subject><subject>Blood</subject><subject>Bone marrow</subject><subject>Cancer therapies</subject><subject>Case Report</subject><subject>Case reports</subject><subject>Chemotherapy</subject><subject>Chronic illnesses</subject><subject>Cytotoxicity</subject><subject>Kinases</subject><subject>Leukemia</subject><subject>Lung cancer</subject><subject>Lymphatic system</subject><subject>Metastasis</subject><subject>Mutation</subject><subject>Myelodysplastic syndromes</subject><subject>Radiation</subject><subject>Steroids</subject><subject>Tomography</subject><subject>Tumors</subject><issn>1792-1074</issn><issn>1792-1082</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2025</creationdate><recordtype>article</recordtype><recordid>eNpVUclqw0AMNaWFhjTH3gd6djqL115KCN0g0Et6HuSxHE9qe9yZcUr-vs5CoNJBgifek_SC4J7Ruchy_miaOac8mrMoTdOrYMLSnIeMZvz60qfRbTBzbkvHiBOWZckk2K0tgm-x88RUpBm6DYESO6PAKt2ZFsiv9jVRNbbG12ih35Mam96RVnu9AY8jZk2nFWn32BhdkgaHb8BWA-mt2Vh0TpvuiSyIAofEYm-svwtuKmgczs51Gny9vqyX7-Hq8-1juViFSlDuQ66KtMwF5nlalpFQWEUwpoKYxyUvBGaUMZYAL2IqqiQvoGJpVMQg4jjPBBfT4PnE2w9Fi6Ua77TQyN7qFuxeGtDyP9LpWm7MTjIWR3z85cjwcGaw5mdA5-XWDLYbl5aCiSihND_qhKcpZY1zFquLBKPy4I80jTz4I4_-iD9qQYZv</recordid><startdate>20250101</startdate><enddate>20250101</enddate><creator>Nagasue, Kazunori</creator><creator>Kida, Ryotaro</creator><creator>Shigaki, Ryota</creator><creator>Nitanai, Kiichi</creator><creator>Yagita, Akari</creator><creator>Yanada, Hiraku</creator><creator>Umekage, Yasuhiro</creator><creator>Mori, Chie</creator><creator>Minami, Yoshinori</creator><creator>Funayama, Takuya</creator><creator>Yamamoto, Masayo</creator><creator>Tanino, Mishie</creator><creator>Yoshida, Ryohei</creator><creator>Sasaki, Takaaki</creator><general>Spandidos Publications UK Ltd</general><general>D.A. Spandidos</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope></search><sort><creationdate>20250101</creationdate><title>Treatment of lung adenocarcinoma with chemotherapy helps mitigate chronic myeloid leukaemia progression: A case report</title><author>Nagasue, Kazunori ; Kida, Ryotaro ; Shigaki, Ryota ; Nitanai, Kiichi ; Yagita, Akari ; Yanada, Hiraku ; Umekage, Yasuhiro ; Mori, Chie ; Minami, Yoshinori ; Funayama, Takuya ; Yamamoto, Masayo ; Tanino, Mishie ; Yoshida, Ryohei ; Sasaki, Takaaki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c302t-2cb7d93e997dd43cef4a4a4ca525d2b3e801116a2b503f69baf174b5a35598323</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2025</creationdate><topic>Biopsy</topic><topic>Blood</topic><topic>Bone marrow</topic><topic>Cancer therapies</topic><topic>Case Report</topic><topic>Case reports</topic><topic>Chemotherapy</topic><topic>Chronic illnesses</topic><topic>Cytotoxicity</topic><topic>Kinases</topic><topic>Leukemia</topic><topic>Lung cancer</topic><topic>Lymphatic system</topic><topic>Metastasis</topic><topic>Mutation</topic><topic>Myelodysplastic syndromes</topic><topic>Radiation</topic><topic>Steroids</topic><topic>Tomography</topic><topic>Tumors</topic><toplevel>online_resources</toplevel><creatorcontrib>Nagasue, Kazunori</creatorcontrib><creatorcontrib>Kida, Ryotaro</creatorcontrib><creatorcontrib>Shigaki, Ryota</creatorcontrib><creatorcontrib>Nitanai, Kiichi</creatorcontrib><creatorcontrib>Yagita, Akari</creatorcontrib><creatorcontrib>Yanada, Hiraku</creatorcontrib><creatorcontrib>Umekage, Yasuhiro</creatorcontrib><creatorcontrib>Mori, Chie</creatorcontrib><creatorcontrib>Minami, Yoshinori</creatorcontrib><creatorcontrib>Funayama, Takuya</creatorcontrib><creatorcontrib>Yamamoto, Masayo</creatorcontrib><creatorcontrib>Tanino, Mishie</creatorcontrib><creatorcontrib>Yoshida, Ryohei</creatorcontrib><creatorcontrib>Sasaki, Takaaki</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>British Nursing Database</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Oncology letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nagasue, Kazunori</au><au>Kida, Ryotaro</au><au>Shigaki, Ryota</au><au>Nitanai, Kiichi</au><au>Yagita, Akari</au><au>Yanada, Hiraku</au><au>Umekage, Yasuhiro</au><au>Mori, Chie</au><au>Minami, Yoshinori</au><au>Funayama, Takuya</au><au>Yamamoto, Masayo</au><au>Tanino, Mishie</au><au>Yoshida, Ryohei</au><au>Sasaki, Takaaki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Treatment of lung adenocarcinoma with chemotherapy helps mitigate chronic myeloid leukaemia progression: A case report</atitle><jtitle>Oncology letters</jtitle><date>2025-01-01</date><risdate>2025</risdate><volume>29</volume><issue>1</issue><artnum>31</artnum><issn>1792-1074</issn><eissn>1792-1082</eissn><abstract>Treatment outcomes for inoperable advanced non-small cell lung cancer have improved in recent years. However, information on coexisting haematological tumours is lacking. The present patient was a 65-year-old woman with stage IVA lung adenocarcinoma. The patient was administered a combination of platinum therapy and immune checkpoint inhibitors. The patient was subsequently diagnosed with chronic myeloid leukaemia (CML) following leukocytosis. Carboplatin and pemetrexed combination therapy resulted in shrinkage of lung cancer. Improvements in peripheral blood leukocyte counts and bone marrow findings were observed. These results suggested that the treatment of lung cancer may control the course of CML.</abstract><cop>Athens</cop><pub>Spandidos Publications UK Ltd</pub><doi>10.3892/ol.2024.14777</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1792-1074
ispartof Oncology letters, 2025-01, Vol.29 (1), Article 31
issn 1792-1074
1792-1082
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11542147
source PubMed
subjects Biopsy
Blood
Bone marrow
Cancer therapies
Case Report
Case reports
Chemotherapy
Chronic illnesses
Cytotoxicity
Kinases
Leukemia
Lung cancer
Lymphatic system
Metastasis
Mutation
Myelodysplastic syndromes
Radiation
Steroids
Tomography
Tumors
title Treatment of lung adenocarcinoma with chemotherapy helps mitigate chronic myeloid leukaemia progression: A case report
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T05%3A21%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Treatment%20of%20lung%20adenocarcinoma%20with%20chemotherapy%20helps%20mitigate%20chronic%20myeloid%20leukaemia%20progression:%20A%20case%20report&rft.jtitle=Oncology%20letters&rft.au=Nagasue,%20Kazunori&rft.date=2025-01-01&rft.volume=29&rft.issue=1&rft.artnum=31&rft.issn=1792-1074&rft.eissn=1792-1082&rft_id=info:doi/10.3892/ol.2024.14777&rft_dat=%3Cproquest_pubme%3E3134600932%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c302t-2cb7d93e997dd43cef4a4a4ca525d2b3e801116a2b503f69baf174b5a35598323%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3134600932&rft_id=info:pmid/&rfr_iscdi=true